Study Stopped
Low accruals
Cancer Within a Pandemic: A Telemental Health Intervention
3 other identifiers
interventional
10
1 country
1
Brief Summary
The purpose of this research study is to test an online support group designed to help young adults who have had cancer treatment to manage their mood during a pandemic. Investigators hope to learn more about what effects a support group may have upon the health and well-being of young adults who have undergone cancer treatment by offering an online support group that teaches healthy coping skills in a practical and acceptable way. Investigators would also like to know if certain parts of the online material is more effective in helping subjects manage their mood.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Mar 2021
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2020
CompletedFirst Posted
Study publicly available on registry
December 9, 2020
CompletedStudy Start
First participant enrolled
March 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2021
CompletedResults Posted
Study results publicly available
October 16, 2025
CompletedOctober 16, 2025
September 1, 2025
3 months
December 2, 2020
August 20, 2025
September 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Self-Efficacy in Pandemic Conditions
The improvement of self-efficacy for young adult cancer survivors navigating pandemic conditions will be assessed by comparing the change in the Cancer Behaviour Inventory-Brief (CBI-B) version (a 12-item validated questionnaire used widely as a measure of self-efficacy for coping with cancer) from baseline to Visit 8. To test the change over the 8 weeks, a paired t-test (using the baseline and Visit 8 scores within the same patient) will be used; the expected difference in the CBI-B between the two scores would be no change. Score range is 1 (not at all confident) to 9 (totally confident) (minimum score of 12, maximum score of 108). Sum the scores for the 12 items with higher scores indicating greater coping efficacy.
At baseline up to 8 weeks
Secondary Outcomes (3)
Changes in Depression and Anxiety Levels (CAS)
At baseline up to 8 weeks
Changes in Depression and Anxiety Levels (PIL)
At baseline up to 8 weeks
Changes in Depression and Anxiety Levels (MAC)
At baseline up to 8 weeks
Study Arms (1)
Telemental Group
EXPERIMENTALThe virtual group will be conducted within a secure platform such as Microsoft WebEx. Assessments (pre-, post-, mid-way) will be distributed through REDCap, a secure virtual platform, as will session handouts and forms.
Interventions
Participants will complete initial online questionnaires lasting about 25-30 minutes as well as attend weekly support group meetings online. After 4 weeks, participants will complete seven online follow-up questionnaires that should take no longer than 30 minutes and again at the end of the study.
Eligibility Criteria
You may qualify if:
- Documented cancer diagnosis within the Wake Forest Baptist Medical Center medical record;
- Outpatient Cancer Survivor (diagnosis, treatment, or post-treatment);
- Aged 18-39
- Must speak English
- Must have computer with audio and visual capabilities.
- Must live within North Carolina
- Must have experienced health-related anxiety and/or distress in last 3 months.
You may not qualify if:
- Active inpatient hospitalization
- Major cognitive impairment, marked concerns with working memory, concentration, or word finding difficulties that significantly impairs daily functioning documented in most recent clinic note or self-reported
- Recent suicide attempt(s), psychiatric hospitalization, or psychotic processing (last 3 years)
- Bipolar disorder (I or II) diagnosis, as evidenced by an ICD-10 code within the past year or revealed during subject interview
- Moderate to severe alcohol or drug abuse; as evidenced by an ICD-10 codes related to alcohol or illicit substance abuse in the medical record within the past year or revealed during subject interview.
- Severe eating disorders; as evidenced by an ICD-10 code in the medical record such as anorexia nervosa or bulimia within the past year or revealed during patient interview
- Repeated "acute" crises for example: repeated acute crises consisting of marked psychological distress that impairs function and warrants clinician intervention (e.g., occurring once a month or more frequently); this we be evaluated by the clinician screener.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest Baptist Health Sciences
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Principal Investigator
- Organization
- Wake Forest Baptist Comprehensive Cancer Center
Study Officials
- PRINCIPAL INVESTIGATOR
Katie Duckworth, Ph.D
Wake Forest University Health Sciences
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2020
First Posted
December 9, 2020
Study Start
March 10, 2021
Primary Completion
June 9, 2021
Study Completion
June 9, 2021
Last Updated
October 16, 2025
Results First Posted
October 16, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share